Tadayasu, Y. et al. 2013. Population Pharmacokinetic/Pharmacodynamic Analysis of the DPP-4 Inhibitor Linagliptin in Japanese Patients with Type 2 Diabetes Mellitus. Journal of Pharmacy & Pharmaceutical Sciences. 16, 5 (Dec. 2013), 708–721. DOI:https://doi.org/10.18433/J3S304.